Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus (DM) is a major risk factor for cardiovascular disease (CVD), significantly increasing heart failure (HF) incidence and severity.
• Diabetic patients with HF exhibit poorer prognoses compared to non-diabetic individuals.
• DM contributes to HF through micro- and macrovasculopathy, direct myocardial effects, and metabolic dysregulation.

Purpose of the Study:

• To review the epidemiology, pathophysiology, and treatment strategies for heart failure in patients with diabetes mellitus.
• To highlight the unique challenges and outcomes associated with HF in the diabetic population.
• To discuss current and emerging therapeutic approaches for heart failure in the context of diabetes.

Main Methods:

• Literature review summarizing epidemiological data, pathophysiological mechanisms, and clinical trial outcomes.
• Analysis of the impact of hyperglycemia, hyperinsulinemia, and insulin resistance on cardiovascular function.
• Evaluation of current treatment guidelines and ongoing research for HF in diabetic patients.

Main Results:

• Diabetes elevates HF risk 2-4 fold and is linked to worse HF prognosis.
• Pathophysiological mechanisms include vascular dysfunction, inflammation, and direct myocardial damage.
• Guideline-directed medical therapy improves outcomes in HF with reduced ejection fraction (HFrEF); efficacy in HF with preserved ejection fraction (HFpEF) is under investigation.

Conclusions:

• Diabetes profoundly impacts cardiovascular health, increasing HF risk and worsening prognosis.
• Understanding the interplay between DM and HF pathophysiology is crucial for effective management.
• Further research, including trials on sodium-glucose cotransporter-2 inhibitors, is needed to optimize HF treatment in diabetic patients, particularly for HFpEF.